Fundamental Analysis of Catalyst Biosciences Inc - Growth / Value Index


CBIO - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Price to Book Ratio of 47150.94 suggesting that it is very expensive
   Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -31082.94 -178.44 -998.39 %
Price to Book 47150.94 126.56 264.05 % 251702
Price to Sales -279746.42 1852.22 851.47 %
Enterprise Value to EBITDA Multiple -141.79 -208.58 -1218.28 %


CBIO - Profitability Highlights

Profitability Analysis

   Gives Dividend Yield of 792.92 %
   Strong Return On Capital Employed of 38.00
   Company Earning excess return
   During the past twelve months, the company has given a strong Net Margin of 900.00%
   All key Trailing Twelve Months Margin growing by 15 %
   Piotroski F Score - Very Poor Value of 2.0
   Negative Net profit for last two years
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 0 0 0 % -44.81
Return On Asset -35.53 -28.98 81.66 % -15.82
Net Profit Margin 900.00 -1038.04 13.38 % 0
Operating Profit Margin 936.15 -1084.51 9.46 % 0
EBITDA Margin 767.13 -874.94 26.71 % 0


Highlights
Market Cap885269 K
Enterprise Value863641 K
Price/Book TTM47150.94
Outstanding Share37978.10 K
Float/ Outstanding Share4.82%
Dividend Yield792.92 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score2.00
Altman Z Score11.02
Sloan Ratio0.874
Peter Lynch Fair Value0


CBIO - Growth Highlights

Growth Analysis

   Quarterly sales in last 5 years is trending up
   Tsr Growth Index - Very Poor Score of 7.57
   Companies' sales dropped by 89.18 % from last year
   Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue -794000.00 89.18 % %
Gross Profit -1592.00 K 99.95 % %
EBITDA -6091.00 K 92.07 % 36.15 %
Net Profit -7146.00 K 90.63 % 36.25 %
EPS -0.0007 90.90 % NA


CBIO - Stability Highlights

Stability Analysis

   Altman Z Score of 11.02 suggests good Stability
   Paid More Than 50% of Debt, Heading towards debt free
   Debt to equity ratio has decreased and is lowest in last five years
   Tsr Stability Index - Very Poor Score of 5.00
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -10.01
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio -0.0018 -103.64 % 0
Cash Ratio 1.29 -61.06 %
Quick Ratio 0 0 % 2.22
Shareholders Equity -76.25 -203.30 %
Debt to EBITDA -0.0055 75.76 %


Historical Valuation Ratios of Catalyst Biosciences Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Catalyst Biosciences Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Catalyst Biosciences Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Catalyst Biosciences Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)